Claire Friedman on Considerations for Older Patients Receiving Immunotherapy

Video

Claire Friedman discusses the factors clinicians should consider when determining an immunotherapy treatment plan for older patients.

Claire Friedman, MD, Memorial Sloan Kettering Cancer Center, discusses considerations to take when planning immunotherapy treatments for older patients. There is also the possibility of combinations to consider.

When choosing an appropriate immunotherapy agent for an older patient, clinicians should discuss the different options, and their risks and benefits, with patients. Clinicians should keep several factors in mind. Not only are a patient’s lifestyle and medical history important, but so is their social support.

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.